Leerink Partners
Fund of funds · New York · United States
Stages
Investment region
Industries
Profile
Leerink Partners is a healthcare-focused investment bank headquartered in Boston, Massachusetts, founded in 1995. The firm is known for its specialized team of experts who provide advisory services in mergers and acquisitions, capital raising, and strategic financial solutions. With a team of 470 employees, Leerink Partners has established itself as a trusted partner for healthcare companies and their investors, leveraging decades of experience across biopharma, digital health, health tech, and medical technology sectors. Leerink Partners primarily invests in the healthcare sector, focusing on biopharmaceuticals, medical devices, diagnostics, and healthcare services. The firm is involved in various stages of investment, including Series A and beyond, with typical check sizes ranging from $3 million to $10 million. Leerink Partners has raised over $206 billion in capital and completed 1,376 transactions as of June 2026. The firm manages funds such as Leerink Transformation Partners I and LEERINK Revelation Healthcare Fund I. Notable investments by Leerink Partners include LB Pharmaceuticals - a company focused on psychiatric treatments, Vidya Therapeutics - specializing in innovative therapeutics, and Processa Pharmaceuticals - a biopharmaceutical company. The firm has also acted as a placement agent for companies like Entera Bio and Scribe Therapeutics, showcasing its extensive network and expertise in the healthcare investment landscape.
Contatti (2)
| Nome | Title | Telefono | ||
|---|---|---|---|---|
| Chairman and CEO Leerink Partners | — | — | — | |
| Vice President Healthcare Investment Banking | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.